We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
AUM
$3.81B
AUM Growth
+$1.88B
Cap. Flow
+$1.94B
Cap. Flow %
50.99%
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727

Sector Composition

Rank Sector Weight
1 Financials 16.84%
2 Technology 16.54%
3 Industrials 11.45%
4 Healthcare 11.32%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIB icon
776
Grupo Cibest SA
CIB
$21.1B
$1.43M 0.04%
+22,456
New +$1.34M
IOVA icon
777
Iovance Biotherapeutics
IOVA
$2.14B
$1.43M 0.04%
522,934
+312,413
+148% +$723K
BEN icon
778
Franklin Resources
BEN
$17.3B
$1.43M 0.04%
59,681
+36,790
+161% +$845K
NVRI icon
779
Enviri
NVRI
$607M
$1.43M 0.04%
+79,556
New +$1.19M
AIV
780
Aimco
AIV
$378M
$1.42M 0.04%
+239,746
New +$1.44M
KN icon
781
Knowles
KN
$3.08B
$1.42M 0.04%
+66,428
New +$1.51M
CB icon
782
Chubb
CB
$141B
$1.42M 0.04%
+4,558
New +$1.33M
VISN
783
Vistance Networks Inc
VISN
$2.61B
$1.42M 0.04%
78,142
+30,027
+62% +$518K
UHAL icon
784
U-Haul Holding Co
UHAL
$14.4B
$1.42M 0.04%
+28,081
New +$1.49M
GOSS icon
785
Gossamer Bio
GOSS
$105M
$1.41M 0.04%
456,329
+181,547
+66% +$518K
CPRI icon
786
Capri Holdings
CPRI
$1.87B
$1.41M 0.04%
57,907
+41,159
+246% +$952K
CGON icon
787
CG Oncology
CGON
$6.34B
$1.4M 0.04%
+33,710
New +$1.39M
CLDX icon
788
Celldex Therapeutics
CLDX
$2.78B
$1.4M 0.04%
51,523
+43,629
+553% +$1.15M
BCE icon
789
BCE
BCE
$20.3B
$1.4M 0.04%
+58,739
New +$1.37M
LRN icon
790
Stride
LRN
$4.04B
$1.4M 0.04%
+21,534
New +$1.96M
KMB icon
791
Kimberly-Clark
KMB
$37.9B
$1.4M 0.04%
13,851
+6,842
+98% +$748K
XRAY icon
792
Dentsply Sirona
XRAY
$2.68B
$1.4M 0.04%
+122,050
New +$1.43M
WEX icon
793
WEX
WEX
$6.16B
$1.39M 0.04%
+9,315
New +$1.4M
TWO
794
Two Harbors Investment
TWO
$1.27B
$1.38M 0.04%
131,618
+116,766
+786% +$1.17M
EWTX icon
795
Edgewise Therapeutics
EWTX
$4.28B
$1.38M 0.04%
+55,620
New +$1.12M
CHA
796
Chagee Holdings Ltd
CHA
$2.24B
$1.38M 0.04%
118,637
+48,633
+69% +$722K
IEF icon
797
iShares 7-10 Year Treasury Bond ETF
IEF
$47.4B
$1.38M 0.04%
+14,337
New +$1.39M
LENZ
798
LENZ Therapeutics
LENZ
$180M
$1.37M 0.04%
+85,782
New +$2.5M
WSFS icon
799
WSFS Financial
WSFS
$4.21B
$1.37M 0.04%
+24,846
New +$1.36M
SCHL icon
800
Scholastic
SCHL
$766M
$1.37M 0.04%
+46,194
New +$1.32M

Similar funds

XTX Topco's Q4 2025 Portfolio in Review

As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.

  • XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
  • XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
  • XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
  • XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
  • XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
  • XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
  • XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.